Suppr超能文献

非小细胞肺癌——肿瘤生物学

Non-Small Cell Lung Cancer-Tumor Biology.

作者信息

Rojiani Mumtaz V, Rojiani Amyn M

机构信息

Department of Pathology, Penn State College of Medicine, Hershey, PA 17033, USA.

Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA 17033, USA.

出版信息

Cancers (Basel). 2024 Feb 8;16(4):716. doi: 10.3390/cancers16040716.

Abstract

Lung cancer is one of the leading causes of cancer-related mortality worldwide among men and women [...].

摘要

肺癌是全球男性和女性中与癌症相关死亡的主要原因之一[...]。

相似文献

1
Non-Small Cell Lung Cancer-Tumor Biology.
Cancers (Basel). 2024 Feb 8;16(4):716. doi: 10.3390/cancers16040716.
2
The role of selected non-coding RNAs in the biology of non-small cell lung cancer.
Adv Med Sci. 2023 Mar;68(1):121-137. doi: 10.1016/j.advms.2023.02.004. Epub 2023 Mar 16.
3
SEOM guidelines for the management of non-small-cell lung cancer (NSCLC).
Clin Transl Oncol. 2009 May;11(5):284-9. doi: 10.1007/s12094-009-0356-4.
5
Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer.
Lung Cancer (Auckl). 2015 May 15;6:35-42. doi: 10.2147/LCTT.S69114. eCollection 2015.
6
Current status of research and treatment for non-small cell lung cancer in never-smoking females.
Cancer Biol Ther. 2017 Jun 3;18(6):359-368. doi: 10.1080/15384047.2017.1323580. Epub 2017 May 11.
8
Anti-angiogenic agents in the treatment of non-small cell lung cancer.
Kardiochir Torakochirurgia Pol. 2014 Jun;11(2):145-50. doi: 10.5114/kitp.2014.43841. Epub 2014 Jun 29.

引用本文的文献

3
Function of antigen-presenting cells in non-small-cell lung cancer (NSCLC).
Med Oncol. 2025 Apr 12;42(5):162. doi: 10.1007/s12032-025-02703-7.
4
The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy.
Pharmaceutics. 2024 Jul 23;16(8):969. doi: 10.3390/pharmaceutics16080969.

本文引用的文献

1
Patient-derived xenograft models in cancer therapy: technologies and applications.
Signal Transduct Target Ther. 2023 Apr 12;8(1):160. doi: 10.1038/s41392-023-01419-2.
2
Targeting glycolysis in non-small cell lung cancer: Promises and challenges.
Front Pharmacol. 2022 Nov 30;13:1037341. doi: 10.3389/fphar.2022.1037341. eCollection 2022.
3
Updated Prognostic Factors in Localized NSCLC.
Cancers (Basel). 2022 Mar 9;14(6):1400. doi: 10.3390/cancers14061400.
4
Lung microbiome alterations in NSCLC patients.
Sci Rep. 2021 Jun 3;11(1):11736. doi: 10.1038/s41598-021-91195-2.
5
Mechanisms of resistance to chemotherapy in non-small cell lung cancer.
Arch Pharm Res. 2021 Feb;44(2):146-164. doi: 10.1007/s12272-021-01312-y. Epub 2021 Feb 19.
6
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.
J Transl Med. 2020 Mar 6;18(1):123. doi: 10.1186/s12967-020-02286-z.
7
Global Epidemiology of Lung Cancer.
Ann Glob Health. 2019 Jan 22;85(1):8. doi: 10.5334/aogh.2419.
8
Revisiting the hallmarks of cancer.
Am J Cancer Res. 2017 May 1;7(5):1016-1036. eCollection 2017.
9
Therapeutic management options for stage III non-small cell lung cancer.
World J Clin Oncol. 2017 Feb 10;8(1):1-20. doi: 10.5306/wjco.v8.i1.1.
10
Non-small-cell lung cancer.
Nat Rev Dis Primers. 2015 May 21;1:15009. doi: 10.1038/nrdp.2015.9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验